4 completed, 1 withdrawn. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Withdrawn 1 |
Follow Amyvid: new trials by email Literature Review of Amyvid trials Research Report on Amyvid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound Neuronavigation-guided single-element focused ultrasound transducer, Definity, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease | Not applicable | Completed | Columbia University | 6 | 2020-08-06 | 2024-08-26 |
| Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians Florbetapir (18F) - Alzheimer's Disease | Not applicable | Withdrawn | Avid Radiopharmaceuticals | 2014-10-01 | 2014-10-23 | |
| Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans florbetapir F 18 - Alzheimer Disease, Mild Cognitive Impairment | Not applicable | Completed | Avid Radiopharmaceuticals | 151 | 2011-08-01 | 2012-06-07 |
| Evaluation of Physician Training Methods to Read Florbetapir-PET Scans florbetapir F 18 - Alzheimer's Disease | Not applicable | Completed | Avid Radiopharmaceuticals | 35 | 2011-01-01 | 2012-06-07 |
| Evaluation of PET Scan Timing Relative to AV-45 Injection Time florbetapir F 18 - Alzheimer's Disease | Not applicable | Completed | Avid Radiopharmaceuticals | 41 | 2010-03-01 | 2012-06-07 |
Alzheimer Disease (5) · Cognitive Dysfunction (1) · Neurodegenerative Diseases (1)
Avid Radiopharmaceuticals (4) · Columbia University (1)
Japan (1) · United States (1)
R01AG038961 (1)